Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice

Tabula Rasa HealthCare50 enrolled

Overview

The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.

The specific aim of this study is to implement a Medication Therapy Management (MTM) service in primary care that is enhanced by the incorporation of pharmacogenomics (PGx) and medication risk mitigation (MRM) factor technology and is standardized by a systematic approach to evidence- and personalized-based medicine. The primary objective is to implement the systematic approach to delivering an enhanced MTM service in a primary care setting. Secondary objectives include: determine how successful the communication between prescriber and pharmacist is within implementing the service, determine how PGx testing can be incorporated into primary care prescribers' daily work flow, determine if patients are receptive to PGx testing, determine how satisfied prescribers are with an enhanced MTM clinical service and their confidence to conduct on their own, and determine if enhanced MTM optimizes or changes drug therapy for patients.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Medication Therapy Management Pharmacogenomics

Interventions

Medication therapy managementOTHER

Implementation of a systematic approach to evidence- and personalized-based medicine through a pharmacist-guided medication therapy management service

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Receiving primary health care from Elmwood Family Physicians; and * Medicare beneficiary; and * Currently prescribed at least 7 medications, or prescriber feels patient would benefit from enhanced medication therapy management, or actual or suspected medication-related problem Exclusion Criteria: * Not willing to participate in the study and sign informed consent; or * Non-English speaking or designated surrogate as translator not available

Locations (1)

Elmwood Family Physicians

Marlton, New Jersey, United States

Outcomes

Primary Outcomes

Qualitative description of process-related challenges and successes as assessed by observation and survey

Implementation

Time frame: 3 months

Secondary Outcomes

Quantitative description of bidirectional communication as assessed by turn-around times from pharmacist's recommendations delivered to prescriber's responses received

Communication

Time frame: 3 months

Qualitative description of incorporation of pharmacogenomic testing into workflow and receptiveness as assessed by observation and survey

Pharmacogenomic testing

Time frame: 3 months

Qualitative description of prescriber satisfaction with enhanced medication therapy management services as assessed by survey

Prescriber survey

Time frame: 3 months

Qualitative and quantitative description of potential impact of enhanced medication therapy management services on drug regimens as assessed by before-and-after observations

Impact

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.